NKTR
Nektar Therapeutics
$75.10
-$1.14(-1.50%)
49
Overall
40
Value
45
Tech
63
Quality
Market Cap
$1.20B
Volume
565.89K
52W Range
$6.48 - $78.81
Target Price
$128.13
EPS Estimates Overview
| Current Quarter | $-1.84 | Next Quarter | $-2.2 |
| Current Year | $-10.5 | Next Year | $-12.63 |
| QoQ Growth | -19.6% | YoY Growth | -20.3% |
| 3Y EPS CAGR | +76.2% | Target Price | $128.13 |
| Consensus | Buy | Upside | +70.6% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NKTR | $75.10 | -1.5% | 565.89K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |